0001127602-19-033033.txt : 20191118
0001127602-19-033033.hdr.sgml : 20191118
20191118161618
ACCESSION NUMBER: 0001127602-19-033033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191118
FILED AS OF DATE: 20191118
DATE AS OF CHANGE: 20191118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sniecinski Megan
CENTRAL INDEX KEY: 0001781480
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 191227750
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BLVD.
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-11-18
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001781480
Sniecinski Megan
4505 EMPEROR BOULEVARD
SUITE 200
DURHAM
NC
27703
1
Chief Business Officer
Common Stock
2019-11-18
4
P
0
45000
1.45
A
45000
D
/s/ Alane P. Barnes, by power of attorney
2019-11-18